Maternal low molecular weight heparin versus sildenafil citrate for fetal growth restriction: a randomized, parallel groups, open-label clinical trial
Crossref DOI link: https://doi.org/10.1038/s41372-019-0544-1
Published Online: 2019-11-06
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rasheedy, R. http://orcid.org/0000-0003-0230-0966
El Bishry, G.
Tarek, R.
Text and Data Mining valid from 2019-11-06
Version of Record valid from 2019-11-06
Article History
Received: 19 April 2019
Revised: 9 October 2019
Accepted: 28 October 2019
First Online: 6 November 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.